JP2013531681A5 - - Google Patents

Download PDF

Info

Publication number
JP2013531681A5
JP2013531681A5 JP2013518858A JP2013518858A JP2013531681A5 JP 2013531681 A5 JP2013531681 A5 JP 2013531681A5 JP 2013518858 A JP2013518858 A JP 2013518858A JP 2013518858 A JP2013518858 A JP 2013518858A JP 2013531681 A5 JP2013531681 A5 JP 2013531681A5
Authority
JP
Japan
Prior art keywords
seq
functional variant
nucleic acid
use according
e4orf1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013518858A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013531681A (ja
JP5965397B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/043338 external-priority patent/WO2012006512A1/en
Publication of JP2013531681A publication Critical patent/JP2013531681A/ja
Publication of JP2013531681A5 publication Critical patent/JP2013531681A5/ja
Application granted granted Critical
Publication of JP5965397B2 publication Critical patent/JP5965397B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013518858A 2010-07-08 2011-07-08 非アルコール性脂肪肝疾患の予防および治療のためのアデノウイルスａｄ３６ｅ４ｏｒｆ１タンパク質 Expired - Fee Related JP5965397B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36244310P 2010-07-08 2010-07-08
US61/362,443 2010-07-08
PCT/US2011/043338 WO2012006512A1 (en) 2010-07-08 2011-07-08 Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease

Publications (3)

Publication Number Publication Date
JP2013531681A JP2013531681A (ja) 2013-08-08
JP2013531681A5 true JP2013531681A5 (https=) 2014-08-21
JP5965397B2 JP5965397B2 (ja) 2016-08-03

Family

ID=44629893

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518858A Expired - Fee Related JP5965397B2 (ja) 2010-07-08 2011-07-08 非アルコール性脂肪肝疾患の予防および治療のためのアデノウイルスａｄ３６ｅ４ｏｒｆ１タンパク質

Country Status (11)

Country Link
US (2) US8951980B2 (https=)
EP (1) EP2590665B1 (https=)
JP (1) JP5965397B2 (https=)
KR (1) KR101831638B1 (https=)
CN (1) CN103052397B (https=)
AU (1) AU2011274537B9 (https=)
CA (1) CA2803787C (https=)
ES (1) ES2550962T3 (https=)
NZ (1) NZ606236A (https=)
TW (1) TWI531650B (https=)
WO (1) WO2012006512A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2887679C (en) 2012-10-17 2020-12-29 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods for improving glucose uptake
US9354963B2 (en) * 2014-02-26 2016-05-31 Microsoft Technology Licensing, Llc Service metric analysis from structured logging schema of usage data
US10047107B2 (en) 2014-04-23 2018-08-14 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Small molecule analogs of E4orf1
GB201910299D0 (en) * 2019-07-18 2019-09-04 Aouadi Myriam Medical uses, methods and uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1626280B1 (en) * 2004-08-12 2007-02-14 Roche Diagnostics GmbH Method for diagnosing liver fibrosis
US20060045919A1 (en) 2004-08-27 2006-03-02 Samueli Institute Homeopathic compositions and methods for the treatment of cancer
JP2008105945A (ja) * 2005-02-07 2008-05-08 Ajinomoto Co Inc アディポネクチンの分泌促進又は誘導作用を有するアシルアミド化合物
WO2007064836A1 (en) * 2005-11-30 2007-06-07 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Adenovirus 36 e4 orf 1 gene and protein and their uses
AU2006342053A1 (en) * 2005-12-27 2007-10-25 Obetech, Llc Adipogenic adenoviruses as a biomarker for disease
JP2008273938A (ja) * 2007-03-30 2008-11-13 Shiseido Co Ltd アディポネクチン産生促進剤

Similar Documents

Publication Publication Date Title
Amet et al. Human growth hormone–transferrin fusion protein for oral delivery in hypophysectomized rats
Peng et al. Polymeric carriers for nucleic acid delivery: current designs and future directions
Kaur et al. Modified mRNA as a therapeutic tool for the heart
Ferrari et al. Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
US20180258429A1 (en) Sarna compositions and methods of use
JP2017514483A5 (https=)
Duan et al. Exosome-mediated drug delivery for cell-free therapy of osteoarthritis
WO2015075557A2 (en) C/ebp alpha compositions and methods of use
JP2019523648A5 (https=)
Patel et al. Intranasal delivery of biotechnology-based therapeutics
SI2823048T1 (en) A new drug delivery system based on JCV-VLP
Devaney et al. Clinical review: gene-based therapies for ALI/ARDS: where are we now?
WO2018021855A1 (ko) Cas9 단백질 및 가이드 RNA를 포함하는 안질환 치료용 약학 조성물
JP2013531681A5 (https=)
JP2021533825A5 (https=)
EP2822600A1 (en) Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders
WO2021042944A1 (zh) 肌肉靶向的微环dna基因治疗
ES2559106B1 (es) Método de activación de la expresión del gen Pitx2 para promover la regeneración muscular
Janssen et al. Gene based therapies for kidney regeneration
WO2014027608A1 (ja) 褐色脂肪細胞分化誘導剤
Hirose et al. Targeted in vivo gene integration of a secretion-enabled GLP-1 receptor agonist reverses diet-induced non-genetic obesity and pre-diabetes
JP2015505535A5 (https=)
WO2021115141A1 (zh) 一种抑制HTT基因表达的siRNA及其前体和应用
Ogris Nucleic acid based therapeutics for tumor therapy
JPWO2023004437A5 (https=)